Case Study: Investigating raised LFTs

Dr Pipin Singh shares this GP case study.

Stigmata of chronic liver failure, such as jaundice and pruritus, can suggest primary biliary cirrhosis (Photograph: Garry Watson/SPL)
Stigmata of chronic liver failure, such as jaundice and pruritus, can suggest primary biliary cirrhosis (Photograph: Garry Watson/SPL)

A 74-year-old woman had her LFTs checked routinely as part of her annual hypertension screen. Her medical history includes sciatica, hypothyroidism, mild depression and psoriasis. Her current medications include amiloride 5mg once daily, atenolol 50mg nightly, calcipotriol, furosemide 40mg once daily, sertraline 50mg once daily and levothyroxine.

Further history
Her LFTs revealed raised GGT and ALP of 92 and 184 units/L respectively. Further history was taken and revealed that the patient did not drink alcohol and had never taken a statin or other medication potentially affecting her LFTs. However, she did report undergoing a blood transfusion many years ago and also thought that her mother possibly had 'liver cancer' but the details of this were unclear.

The patient denied any abdominal pain and no stigmata of chronic liver disease were noted. She was a smoker, and had reported some fatigue over a couple of months but her hypothyroidism was uncontrolled and recent adjustments had been made to her thyroxine in order to normalise her TSH.

Repeat LFTs four months later showed that both ALP and GGT had increased to 196 and 135 units/L respectively. Based on this, an ultrasound scan and full liver screen were organised. The ultrasound scan was reported as normal; however, the liver screen revealed a positive M2 and anti-mitochondrial antibody. Her cholesterol was also high, at 7.5mmol/L – her cardiovascular risk warranted statin treatment.

After discussion with the biochemist, we agreed to commence low-dose pravastatin and monitor her LFTs. In the event that her LFTs deteriorated on this regimen, ezetimibe would be considered.

The patient was subsequently referred as a case of primary biliary cirrhosis (PBC) to the hepatology department; appropriate treatment has been commenced.

Primary biliary cirrhosis
PBC has an estimated prevalence of 12.9 per 100,000 population. It is more common in females around the fifth decade of life.1 Fatigue is the most common symptom but other symptoms can include pruritus, jaundice and right upper quadrant pain. Look for stigmata of chronic liver disease on examination.

PBC is often diagnosed following further investigation of abnormal LFTs, namely raised ALP and GGT, because the disease involves the biliary tree. Anti-mitochondrial antibody is highly specific for the condition. There is a strong association with other autoimmune conditions, particularly thyroid disease.

Other basic primary care investigations can include ultrasound scan of the abdomen to look for other causes of the deranged LFTs and to see if there is evidence of cirrhosis. Further investigations in secondary care may involve CT or MRI. A liver biopsy may also be indicated to stage the disease.

Treatment focuses on slowing disease progression and alleviating symptoms. Fatigue is difficult to treat; however, pruritus can be treated with sedating antihistamines, emollients and drugs that sequester bile salts to prevent bile salt deposition in the skin.

Ursodeoxycholic acid is used to slow disease progression, with mixed reports as to whether it improves survival. Other treatments involve altering the autoimmune component of the condition, for example with methotrexate.

Transplant is also performed, although the autoimmune process affects the transplanted liver and other problems such as rejection are likely.

  • Dr Singh is a GP in Northumberland

Reference
1. Selmi C, Invernizzi P, Keeffe EB et al. Epidemiology and pathogenesis of primary biliary cirrhosis. J Clin Gastroenterol 2004; 38 (3): 264-71.

KEY POINTS
  • Abnormal LFTs are common in primary care and must be followed up appropriately.
  • Take a careful history, focusing on possible causes for abnormal LFTs.
  • Perform a full liver screen and ultrasound scan if the history, examination or pattern of LFTs dictates.

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register

Already registered?

Sign in

Follow Us:

Just published

UK COVID-19 vaccination programme tracker

UK COVID-19 vaccination programme tracker

GPs across the UK are playing a leading role in the largest-ever NHS vaccination...

GP-led sites behind almost three quarters of COVID-19 jabs in England

GP-led sites behind almost three quarters of COVID-19 jabs in England

GP-led vaccination sites have delivered nearly three quarters of COVID-19 vaccine...

GPs should ignore calls to throw away usable COVID-19 vaccine, says RCGP

GPs should ignore calls to throw away usable COVID-19 vaccine, says RCGP

Suggestions that vaccination sites should throw away usable doses of COVID-19 vaccine...

GPs urged to use influence to dispel COVID-19 vaccine myths and boost BAME uptake

GPs urged to use influence to dispel COVID-19 vaccine myths and boost BAME uptake

GPs have been encouraged to use their ‘huge influence’ to bust misinformation around...

Six in 10 over-80s vaccinated against COVID-19 as figures expose regional variation

Six in 10 over-80s vaccinated against COVID-19 as figures expose regional variation

Six in 10 people aged over 80 in England received a first dose of COVID-19 vaccine...

Summary of changes to the GP contract 2021/22

Summary of changes to the GP contract 2021/22

The BMA and NHS England have agreed minor changes to the GP contract for 2021/22....